Transactions
PHASTAR recapitalized by Charterhouse Capital Partners
Dec. 2020
Client: PHASTAR is a rapidly growing, global specialist biometrics clinical research organization ("CRO") offering statistical consulting, clinical trial reporting, data management, and data science services through both dedicated functional service provider (“FSP”) and expert in-house project management (“Project-Based”) delivery models to pharmaceutical sponsors around the world
Role: Edgemont Partners acted as exclusive financial advisor to PHASTAR in its recapitalization by Charterhouse
Location: London, UK
Sector: Pharmaceutical Services
Lead Banker: David Blume
recapitalized by
